A number of studies demonstrated that NF-κB-dependent inflammatory pathways initiated by TLR4 ligands and cytokines, such as TNF-α and IL-1β, are highly activated in MM-MSCs and are implicated in the changes of these cells in the tumor microenvironment [10,11,12,13]. The gene discussed is IL1B; the disease is Miyoshi myopathy.